Ajooni Biotech Limited (NSE:AJOONI)
India
· Delayed Price · Currency is INR 4.520
+0.100 (2.26%)
Mar 10, 2026, 3:29 PM IST
Ajooni Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,510 | 1,147 | 801.15 | 744.88 | 740.38 | 510.39 | Upgrade
|
| Other Revenue | 11.79 | 11.79 | 1.39 | - | - | - | Upgrade
|
| Revenue | 1,522 | 1,159 | 802.54 | 744.88 | 740.38 | 510.39 | Upgrade
|
| Revenue Growth (YoY) | 44.77% | 44.38% | 7.74% | 0.61% | 45.06% | 27.49% | Upgrade
|
| Cost of Revenue | 1,215 | 970.28 | 703.5 | 657.43 | 640.13 | 430.13 | Upgrade
|
| Gross Profit | 307.3 | 188.44 | 99.04 | 87.45 | 100.24 | 80.26 | Upgrade
|
| Selling, General & Admin | 135.23 | 123.95 | 64.3 | 50.88 | 56.03 | 51.83 | Upgrade
|
| Other Operating Expenses | 95.84 | 14.04 | 7.06 | 6.8 | 11.57 | 11.77 | Upgrade
|
| Operating Expenses | 247.96 | 148.92 | 80.1 | 67.73 | 78.7 | 69.37 | Upgrade
|
| Operating Income | 59.33 | 39.52 | 18.94 | 19.72 | 21.54 | 10.89 | Upgrade
|
| Interest Expense | -1.62 | - | - | - | - | - | Upgrade
|
| Interest & Investment Income | 8.88 | 8.88 | 5.06 | 2.05 | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.47 | -3.34 | -5.29 | -4.77 | -5.4 | -5.84 | Upgrade
|
| EBT Excluding Unusual Items | 67.06 | 45.05 | 18.7 | 16.99 | 16.15 | 5.05 | Upgrade
|
| Other Unusual Items | -1.76 | -1.76 | -1.95 | -1.23 | -1.54 | -0.01 | Upgrade
|
| Pretax Income | 65.3 | 43.29 | 29.96 | 15.77 | 14.61 | 5.04 | Upgrade
|
| Income Tax Expense | 16.11 | 9.57 | 8.35 | 4.52 | 4.12 | 1.31 | Upgrade
|
| Net Income | 49.19 | 33.72 | 21.61 | 11.25 | 10.49 | 3.73 | Upgrade
|
| Net Income to Common | 49.19 | 33.72 | 21.61 | 11.25 | 10.49 | 3.73 | Upgrade
|
| Net Income Growth | 79.32% | 56.02% | 92.16% | 7.24% | 181.14% | 7.57% | Upgrade
|
| Shares Outstanding (Basic) | 103 | 172 | 88 | 60 | 51 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 103 | 172 | 88 | 60 | 51 | 50 | Upgrade
|
| Shares Change (YoY) | -51.30% | 96.59% | 46.51% | 18.35% | 1.00% | 6.46% | Upgrade
|
| EPS (Basic) | 0.48 | 0.20 | 0.25 | 0.19 | 0.21 | 0.07 | Upgrade
|
| EPS (Diluted) | 0.48 | 0.20 | 0.25 | 0.19 | 0.21 | 0.07 | Upgrade
|
| EPS Growth | 268.24% | -20.64% | 31.16% | -9.39% | 180.50% | 0.27% | Upgrade
|
| Free Cash Flow | - | -197.69 | 173.09 | -69.39 | 15.6 | -23.71 | Upgrade
|
| Free Cash Flow Per Share | - | -1.15 | 1.98 | -1.16 | 0.31 | -0.47 | Upgrade
|
| Gross Margin | 20.19% | 16.26% | 12.34% | 11.74% | 13.54% | 15.73% | Upgrade
|
| Operating Margin | 3.90% | 3.41% | 2.36% | 2.65% | 2.91% | 2.13% | Upgrade
|
| Profit Margin | 3.23% | 2.91% | 2.69% | 1.51% | 1.42% | 0.73% | Upgrade
|
| Free Cash Flow Margin | - | -17.06% | 21.57% | -9.32% | 2.11% | -4.65% | Upgrade
|
| EBITDA | 71.91 | 50.45 | 27.68 | 29.77 | 31.24 | 15.26 | Upgrade
|
| EBITDA Margin | 4.72% | 4.35% | 3.45% | 4.00% | 4.22% | 2.99% | Upgrade
|
| D&A For EBITDA | 12.58 | 10.94 | 8.74 | 10.05 | 9.7 | 4.37 | Upgrade
|
| EBIT | 59.33 | 39.52 | 18.94 | 19.72 | 21.54 | 10.89 | Upgrade
|
| EBIT Margin | 3.90% | 3.41% | 2.36% | 2.65% | 2.91% | 2.13% | Upgrade
|
| Effective Tax Rate | 24.68% | 22.11% | 27.87% | 28.68% | 28.22% | 26.02% | Upgrade
|
| Revenue as Reported | 1,535 | 1,168 | 823.08 | 747.82 | 740.76 | 510.56 | Upgrade
|
| Advertising Expenses | - | 0.76 | 0.36 | 0.19 | 0.35 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.